Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.305 USD | +1.95% |
|
-1.88% | -11.22% |
May. 15 | Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M | MT |
May. 15 | Spero Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 27.39M | Sales 2025 * | 34.43M | Capitalization | 70.45M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -72M | EV / Sales 2024 * | 2.57 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-1.03
x | P/E ratio 2025 * |
-1.09
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.58% |
Latest transcript on Spero Therapeutics, Inc.
1 day | +1.95% | ||
1 week | -1.88% | ||
Current month | +0.38% | ||
1 month | -8.10% | ||
3 months | -27.50% | ||
6 months | -14.14% | ||
Current year | -11.22% |
![Extreme 1.27](/images/extremecours_fleche.png)
![Extreme 1.25](/images/extremecours_fleche.png)
![Extreme 1.25](/images/extremecours_fleche.png)
![Extreme 0.99](/images/extremecours_fleche.png)
![Extreme 0.6801](/images/extremecours_fleche.png)
![Extreme 0.6801](/images/extremecours_fleche.png)
![Extreme 0.6801](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 21-01-03 |
Ankit Mahadevia
FOU | Founder | 43 | 13-03-31 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | Nov. 05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 17-06-30 |
John Pottage
BRD | Director/Board Member | 71 | 18-08-13 |
Scott Jackson
BRD | Director/Board Member | 59 | 20-04-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 1.305 | +1.95% | 34,444 |
24-07-01 | 1.28 | -1.54% | 92,403 |
24-06-28 | 1.3 | -2.99% | 47,354 |
24-06-27 | 1.34 | +0.75% | 54,156 |
24-06-26 | 1.33 | 0.00% | 51,471 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.22% | 70.45M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.86% | 26.22B | |
-25.37% | 19.01B | |
-20.65% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- SPRO Stock